“Beyond Weight Loss: Practical Considerations for Use of Glucagon Like Peptide-1 (GLP-1) and Incretin Therapy in Inflammatory Skin Disease”. 2026. Canadian Dermatology Today 7 (3): 11-16. https://doi.org/10.58931/cdt.2026.73168.